Wolverine (BPC-157 + TB-500) vs Glow (BPC-157 + TB-500 + GHK-Cu)
Wolverine (BPC-157 + TB-500) and Glow (BPC-157 + TB-500 + GHK-Cu) are research peptide blends built on the same two repair-associated peptides. Wolverine pairs BPC-157, studied for angiogenic and epithelial signaling, with TB-500, studied for actin regulation and repair-cell migration. Research has explored whether these mechanisms are complementary, and BPC-157 has been studied in soft tissue and wound healing. Glow adds GHK-Cu, the copper peptide most studied for copper-dependent collagen synthesis, skin remodeling, and gene expression. That added structural remodeling component is the main mechanistic difference. Neither blend has been evaluated as a combination in published studies. Human safety data are limited for both, and evidence for the components comes largely from preclinical work and reviews.
Key differences. In plain words.
- 01
Wolverine contains two peptides, BPC-157 and TB-500 at 5 mg each, while Glow adds a third component, the copper peptide GHK-Cu.
- 02
Glow's mechanism extends beyond repair signaling and actin regulation to include copper-dependent collagen biology, which Wolverine does not cover.
- 03
Wolverine is classed as early-clinical because its component evidence includes a small human report on intra-articular BPC-157 for knee pain, while Glow is classed as preclinical, with component research drawn mainly from animal and cell studies and reviews.
- 04
Wolverine sits in the Foundation category with a focus on combined local repair and systemic regeneration, while Glow spans both the Longevity and Foundation categories and adds a focus on skin and connective-tissue renewal.
- 05
Both blends have been studied by the subcutaneous route, but research protocols have used 500–1,000 mcg per administration for Wolverine and 1.75–3.5 mg per administration, given in the morning, for Glow.
Side by side. From the research.
Studied ranges describe what published research protocols have used. They are not instructions or recommendations. Products are sold for research purposes only; each order ships with a protocol guide for the specific product.
Mechanism
How it is thought to work
Wolverine (BPC-157 + TB-500)
The two compounds are studied for different steps in the repair sequence, BPC-157 for angiogenic and epithelial signaling, TB-500 for actin regulation and the migration of repair cells.
Complementary Mechanisms
Pairs a compound studied for vascular and epithelial signaling with one studied for cytoskeletal regulation and cell migration.
Single Reconstitution
Both compounds share a vial, so a protocol using each of them requires one preparation rather than two.
How it is thought to work
Glow (BPC-157 + TB-500 + GHK-Cu)
The blend spans repair signaling and structural remodeling: angiogenic and epithelial pathways, actin regulation, and copper-dependent collagen biology.
Repair Plus Renewal
Combines compounds studied for tissue recovery with one studied specifically for dermal and structural protein synthesis.
Crossover Profile
Sits across Longevity and Foundation, reflecting the mixed repair and renewal focus of its components.
Ask about Wolverine (BPC-157 + TB-500) and Glow (BPC-157 + TB-500 + GHK-Cu)
Plain answers from our library and the cited studies.
AI answers can be wrong. Research use only.

